We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Citations Search

Sort By:

SLAS Technol. 24, 28–40. Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug Efficacy. 2019

Wilson K.M., Mathews-Griner L.A., Williamson T., Guha R., Chen L., Shinn P., McKnight C., Michael S., Klumpp-Thomas C., Binder Z.A., Ferrer M., Gallia G.L., Thomas C.J., Riggins G.J.

Notes: Researchers generated novel glioblastoma 3D cell models to better predict drug efficacy in patients. Two cell lines were used for high-throughput screening, where cell viability and apoptosis assays were used. (5224)

Expand Full Notes »

Cell Death Dis. 7, e2492. Large-scale pharmacological profiling of 3D tumor models of cancer cells 2016

Mathews Griner L.A., Zhang X., Guha R., McKnight C., Goldlust I.S., Lal-Nag M., Wilson K., Michael S., Titus S., Shinn P., Thomas C.J., Ferrer M.

Notes: In this study, researchers used high-throughput compatible 384-well and 1536-well assay plate formats with spheroids of various cell types. Viability and apoptosis of monolayer and 3D tumor models was assessed. (5223)

Expand Full Notes »